We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
Read MoreHide Full Article
A month has gone by since the last earnings report for Omnicell (OMCL - Free Report) . Shares have lost about 0.4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Omnicell due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Omnicell, Inc. reported a third-quarter 2024 adjusted earnings per share (EPS) of 56 cents, which declined 9.7% year over year. However, the metric beat the Zacks Consensus Estimate by 36.6%.
Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses and RDS restructuring.
GAAP EPS was 19 cents, up 58.3% from the 2023 figure.
Q3 Revenues
Revenues totaled $282.4 million, down 5.4% year over year. However, the figure beat the Zacks Consensus Estimate by 1.6%.
Segmental Analysis
On a segmental basis, Product revenues declined 16.1% year over year to $158.4 million in the reported quarter. Our model’s projected revenues of $159.4 million for this segment.
Service and other revenues climbed 12.9% year over year to $124.1 million. Our model estimate was $117.7 million.
Margin Performance
In the quarter under review, the gross profit declined 7.4% year over year to $122.3 million. The gross margin contracted 89 basis points (bps) to 43.4% despite a 4% decline in the cost of revenues.
Operating expenses amounted to $115.7 million, down 9.8% year over year. The operating profit in the quarter totaled $6.6 million, down 76.8% year over year. The operating margin expanded 108 basis points to 2.3%.
Cash Position
Omnicell exited the third quarter of 2024 with cash and cash equivalents of $570.6 million compared with $556.8 million at the end of the second quarter of 2024.
The cumulative cash flow provided by operating activities at the end of the third quarter was $131.4 million compared with $142.7 million in the year-ago period.
Updated 2024 Outlook
Omnicell updated its financial outlook for 2024.
Total revenues are expected to be $1.10-$1.11 billion (versus the previously mentioned $1.07-$1.11 billion). Of this, product revenues are expected to be $625-$630 million (previously $610-$630 million) and service revenues are anticipated to be $475-$480 million (previously $460-$480 million). The Zacks Consensus Estimate for total revenues is pegged at $1.08 billion.
The adjusted EPS for the year is expected to be $1.65-$1.72 (up from the previously projected $1.20-$1.50). The Zacks Consensus Estimate is pegged at $1.40.
For the fourth quarter of 2024, Omnicell expects revenues of $295-$305 million, including product revenues of $177-$182 million and service revenues of $118-$123 million. The Zacks Consensus Estimate for fourth-quarter 2024 revenues is pegged at $278.1 million.
The adjusted EPS for the fourth quarter is expected to be between 55 cents and 62 cents. The Zacks Consensus Estimate is pegged at 41 cents.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates have trended upward during the past month.
The consensus estimate has shifted 47.14% due to these changes.
VGM Scores
Currently, Omnicell has an average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Omnicell has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
A month has gone by since the last earnings report for Omnicell (OMCL - Free Report) . Shares have lost about 0.4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Omnicell due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
OMCL Q3 Earnings & Revenues Beat Estimates, '24 EPS View Raised
Omnicell, Inc. reported a third-quarter 2024 adjusted earnings per share (EPS) of 56 cents, which declined 9.7% year over year. However, the metric beat the Zacks Consensus Estimate by 36.6%.
Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses and RDS restructuring.
GAAP EPS was 19 cents, up 58.3% from the 2023 figure.
Q3 Revenues
Revenues totaled $282.4 million, down 5.4% year over year. However, the figure beat the Zacks Consensus Estimate by 1.6%.
Segmental Analysis
On a segmental basis, Product revenues declined 16.1% year over year to $158.4 million in the reported quarter. Our model’s projected revenues of $159.4 million for this segment.
Service and other revenues climbed 12.9% year over year to $124.1 million. Our model estimate was $117.7 million.
Margin Performance
In the quarter under review, the gross profit declined 7.4% year over year to $122.3 million. The gross margin contracted 89 basis points (bps) to 43.4% despite a 4% decline in the cost of revenues.
Operating expenses amounted to $115.7 million, down 9.8% year over year. The operating profit in the quarter totaled $6.6 million, down 76.8% year over year. The operating margin expanded 108 basis points to 2.3%.
Cash Position
Omnicell exited the third quarter of 2024 with cash and cash equivalents of $570.6 million compared with $556.8 million at the end of the second quarter of 2024.
The cumulative cash flow provided by operating activities at the end of the third quarter was $131.4 million compared with $142.7 million in the year-ago period.
Updated 2024 Outlook
Omnicell updated its financial outlook for 2024.
Total revenues are expected to be $1.10-$1.11 billion (versus the previously mentioned $1.07-$1.11 billion). Of this, product revenues are expected to be $625-$630 million (previously $610-$630 million) and service revenues are anticipated to be $475-$480 million (previously $460-$480 million). The Zacks Consensus Estimate for total revenues is pegged at $1.08 billion.
The adjusted EPS for the year is expected to be $1.65-$1.72 (up from the previously projected $1.20-$1.50). The Zacks Consensus Estimate is pegged at $1.40.
For the fourth quarter of 2024, Omnicell expects revenues of $295-$305 million, including product revenues of $177-$182 million and service revenues of $118-$123 million. The Zacks Consensus Estimate for fourth-quarter 2024 revenues is pegged at $278.1 million.
The adjusted EPS for the fourth quarter is expected to be between 55 cents and 62 cents. The Zacks Consensus Estimate is pegged at 41 cents.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates have trended upward during the past month.
The consensus estimate has shifted 47.14% due to these changes.
VGM Scores
Currently, Omnicell has an average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Omnicell has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.